MIDOSTAURIN for Malignant mast cell neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where MIDOSTAURIN was used for Malignant mast cell neoplasm.
Most Reported Side Effects for MIDOSTAURIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 397 | 13.3% | 396 | 22 |
| Nausea | 252 | 8.4% | 21 | 50 |
| Febrile neutropenia | 223 | 7.5% | 33 | 90 |
| Diarrhoea | 194 | 6.5% | 29 | 59 |
| Pyrexia | 188 | 6.3% | 25 | 90 |
| Acute myeloid leukaemia recurrent | 171 | 5.7% | 29 | 14 |
| Pancytopenia | 152 | 5.1% | 11 | 25 |
| Vomiting | 152 | 5.1% | 25 | 45 |
| Drug ineffective | 151 | 5.1% | 18 | 13 |
| Thrombocytopenia | 140 | 4.7% | 17 | 37 |
| Neutropenia | 136 | 4.5% | 15 | 25 |
| Pneumonia | 128 | 4.3% | 47 | 74 |
| Bone marrow failure | 109 | 3.6% | 13 | 14 |
| Sepsis | 106 | 3.5% | 54 | 50 |
| Anaemia | 97 | 3.2% | 17 | 33 |
Other Indications for MIDOSTAURIN
Acute myeloid leukaemia (1,653)
Product used for unknown indication (688)
Systemic mastocytosis (270)
Myelodysplastic syndrome (45)
Mastocytic leukaemia (36)
Mastocytosis (36)
Leukaemia (28)
Flt3 gene mutation (16)
Acute leukaemia (15)
Myeloid leukaemia (14)